While the overall risk of secondary cancers after Kaposi sarcoma has declined in people with HIV/AIDS, clinicians should be aware that certain cancers are becoming increasingly common in the highly active antiretroviral therapy era compared with the pre-HAART era. READ MORE
Childhood survivors of bone cancer and soft-tissue sarcoma face increased risk of hospitalization for years after initial diagnosis.
Aldoxorubicin improves progression-free survival in patients with metastatic or locally advanced unresectable soft-tissue sarcoma.
Research in Review
Results argue against the inclusion of ifosfamide and etoposide to postoperative chemotherapy in patients with poorly responding osteosarcoma.
Researchers looked at patients diagnosed with non-metastatic soft-tissue sarcoma to determine how different factors correlated with survival.